News for Corteva, Inc. (CTVA)

We came across a bullish thesis on The Mosaic Company on VantagePointAI’s Substack. In this article, we will summarize the bulls’ thesis on MOS. The Mosaic Company’s share was trading at $35.27 as of July 17th. MOS’s trailing and forward P/E were 30.41 and 11.82, respectively according to Yahoo Finance. Mosaic (NYSE: MOS) is no longer just […]

PR NewswireMIDLAND, Mich., July 24, 2025 MIDLAND, Mich., July 24, 2025 /PRNewswire/ -- Dow (NYSE: DOW):

PR NewswireMIDLAND, Mich., July 24, 2025 Adjusting dividend by 50% in response to prolonged industry downturnAligning payout size to ensure capital allocat

/PRNewswire-PRWeb/ -- IBJ Media on Wednesday unveiled its fourth annual Indiana 250, a list of the state's most influential business and community leaders from...

Insightful Analysis of Robert Olstein (Trades, Portfolio)'s Latest 13F Filing Robert Olstein (Trades, Portfolio) recently submitted the 13F filing for the seco

Corteva (CTVA) has received a price target hike from Argus analyst Alexandra Yates, who raised it from $69 to $83 while maintaining a Buy recommendation on the

Corteva is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit growth in earnings.

Corteva, Inc. (CTVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

On July 15, 2025, Oppenheimer analyst Kristen Owen maintained an "Outperform" rating on Corteva (CTVA), a leading agricultural company listed on the NYSE. This

In a recent update, Keybanc Analyst Aleksey Yefremov has maintained an "Overweight" rating for Corteva (CTVA). The analyst, however, has raised the price target

RBC Capital analyst Arun Viswanathan has updated the price target for Corteva (CTVA), raising it from $74.00 USD to $85.00 USD. This adjustment reflects a signi

On July 9, 2025, UBS analyst Joshua Spector maintained a "Buy" rating on Corteva (CTVA), while raising the price target from $76.00 to $90.00 USD. This adjustme

UBS has adjusted its price projection for Corteva (CTVA), elevating it from $76 to $90, while maintaining a Buy recommendation on the stock. This decision refle

Corteva, Inc. (NYSE:CTVA) is one of the 15 successful spin-off companies. On June 18, the company signed a multi-year research and development collaboration with Micropep Technologies, a leader in micropeptide technology for sustainable crop protection. The two are joining forces to co-develop next-generation peptide-based bio-control solutions. Corteva is to hold, on a defined peptide library, […]

Corteva, Inc. (NYSE:CTVA) is one of the 10 best organic food and farming stocks to buy now. On June 23, analysts at Wells Fargo reiterated an ‘Overweight’ rating on the stock and raised their price target to $82 from $79. The price target hike underscores Wells Fargo’s confidence that Corteva is well-positioned to capitalize on […]

On July 7, 2025, Barclays, under the guidance of analyst Benjamin Theurer, announced an update on Corteva (CTVA) by maintaining its "Equal-Weight" rating on the

PR NewswireMIDLAND, Mich., July 7, 2025 Right-sizing upstream regional capacity, reducing merchant sale exposure, and removing higher-cost, energy-intensiv

Market Analysis by covering: S&P 500, Newmont Goldcorp Corp, Crude Oil WTI Futures, The Materials Select Sector SPDR® Fund. Read 's Market Analysis on Investing.com

Wells Fargo has increased its price target for Corteva (CTVA) stock, raising it to $82 from the previous target of $79 while maintaining an Overweight rating. A